Survivor Profile Sharing Her Strength Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer. by Lindsey Konkel Medicare Coverage for Next-Generation Sequencing Tests Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests. by Ashley P. Taylor BRCA: Who Should Be Tested? Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out. by Sue Rochman Our Own Words People with cancer and their loved ones find ways for their voices to be heard without filters. by Bradley Jones Finding Support in Unlikely Places After her diagnosis with ovarian cancer, Patricia Anne Ward noticed that some friends and family pulled away. She found connection outside her usual circles. by Patricia Anne Ward Advocacy Spotlight: Sorting Out Priorities Ovarian cancer survivor and research advocate Annie Ellis is teaming up with researchers to better equip patients with recurrent cancer to make treatment decisions. by Cici Zhang Forward Look Little Consensus on Ovarian Cancer Monitoring Tests and scans may be overused. by Kate Yandell Survivor Profile Going Full Bore Susan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense. by Sue Rochman Forward Look Identifying Ovarian Cancer Risk Study may help spotlight women who would benefit from risk reduction strategies. by Carrie Printz Healthy Habits A Cup of Tea? Black tea consumption may be associated with a reduced risk of ovarian cancer. by Kurt Ullman next Cancer Talk Survival Statistics 101 Survival statistics are important—and sometimes confusing. Cancer Today spoke with statistics experts about what these numbers really mean. by Ashley P. Taylor Patient Advocates Tune in for Precision Medicine Primer Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers. by Kevin McLaughlin Testing COVID-19 Treatments for Patients With Cancer: An Ongoing Need Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus. by Marcus A. Banks Immunotherapy Options for Breast Cancer Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions. by Anna Goshua More Posts